CrushSCI.com
提供学术论文选刊润色服务
Molecular Therapy Oncology 期刊封面 医学
返回期刊列表

Review Cycle Records

Molecular Therapy Oncology

Elsevier SCIE 非OA
2026新锐 2区2025中科院 暂无数据2025 JCR Q1
184.1平均天数
159中位天数
55最短天数
490最长天数
1642025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

109 天

USP15 regulates mitotic fidelity, metastatic potential, and chemotherapeutic response in ovarian cancer cells

作者Ayokunnumi Ogunsanya; Fatimah Alfaran; Omuya Noel Amadu; Achuth Padmanabhan

作者单位Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, USA; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA

PDF源文件 DOI 网页
159 天

Ultrasound controllable and antigen-independent killing via cis-activating CAR T cells

作者Linshan Zhu; Jiaxin Cui; Chi-Wei Man; Anthony Mouchawar; Xi Yu; Yixuan Huang; Yiqian Wu; Tianze Guo; Hongquan Xu; Longwei Liu; Yingxiao Wang

作者单位Alfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, Los Angeles, CA 90089, USA; Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093, USA; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, Los Angeles, CA 90089, USA; National Biomedical Imaging Center, College of Future Technology, Peking University, Beijing 100871, China; Department of Statistics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Ophthalmology, Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, Los Angeles, CA 90033, USA; Department of Bioengineering and Institute of Engineering in Medicine, University of California, San Diego, La Jolla, CA 92093, USA

PDF源文件 DOI 网页
260 天

Simultaneous targeting of IL-10 and PD-(L)1 pathways with a bispecific anti-PD-L1/IL-10-trap antibody enhances T cell responses

作者Latika Singh; Natalia Zabavnik; Sambasivan Venkatasubramanian; Sagi Barzilai; Jing Ni; Andreas Evers; Olga Bogatyrova; Melissa G. Derner; Stefan Zielonka; Rinat Zaynagetdinov; Laura Helming

作者单位Research Unit Oncology, EMD Serono Research and Development Institute, Inc., Billerica, MA 01821, USA; Antibody Discovery and Protein Engineering, Inter-Lab Ltd., Yavne 8122004, Israel; Research Unit Oncology, the Healthcare Business of Merck KGaA, 64293 Darmstadt, Germany; Antibody Discovery and Protein Engineering, the Healthcare Business of Merck KGaA, 64293 Darmstadt, Germany; Research Unit Oncology Data Science, the Healthcare Business of Merck KGaA, 64293 Darmstadt, Germany

PDF源文件 DOI 网页
182 天

Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma

作者Zili Zhen; Qiang Gao; Yong Ai; Zhihong Qian; Yukui Shang; Yafang Deng; Shuai Chen; Xin Ni; Wei Zhang

作者单位IDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing 100084, China; Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750003, China; School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 100084, China; Department of Neurosurgery, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing 100045, China; The State Key Laboratory for Complex, Severe, and Rare Diseases, School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing 100084, China; Department of Internal Medicine, Peking Union Medical College Hospital, Beijing 100730, China; Neurological Center, Beijing Children’s Hospital Shunyi Women’s and Children’s Hospital, Beijing 101300, China; National Center for Pediatric Cancer Surveillance, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing 100045, China; Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing 100045, China

PDF源文件 DOI 网页
106 天

Neuroepithelial reprogramming and ERBB vulnerability in canine acanthomatous ameloblastoma

作者Andreas Stephanou; Bo Shui; Deanna Mische; Michael Byron; William P. Katt; Marina Chan; Jennifer K. Grenier; Iwijn De Vlaminck; Gerald E. Duhamel; Taranjit S. Gujral; Praveen Sethupathy; Santiago Peralta

作者单位Department of Biomedical and Translational Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA; Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Clinical Sciences, Clinical Programs Center, College of Veterinary Medicine, Cornell University, Box 31, Ithaca, NY 14853, USA; Biotechnology Resource Center, Cornell University, Ithaca, NY 14853, USA

PDF源文件 DOI 网页
168 天

TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer

作者Audrey Merienne; Kathleen Ducoin; Cécile Deleine; Mathilde Deiber; Margot Machu; Edouard Leveque; Romain Oger; Emilie Duchalais; Pierre Fourquier; Céline Bossard; Nathalie Labarrière; Houssem Benlalam; Anne Jarry; Nadine Gervois-Segain

作者单位Nantes Université, University Angers, CHU Nantes, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, 44000 Nantes, France; LabEx IGO and ImmuNE, Nantes Université, Nantes, France; IRCM, University Montpellier, Inserm, ICM, CNRS, Montpellier, France; University of Toulouse, Infinity, Inserm, CNRS, 31024 Toulouse, France; Nantes Université, University Angers, INSERM, CNRS, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes-Angers, CRCI2NA, UMR 1307/EMR6001, 44000 Nantes, France; Department of Digestive Surgery and IMAD, CHU Nantes, France; Department of Digestive Surgery, Hôpital Privé Du Confluent, Nantes, France; Department of Pathology, CHU Nantes, IHP Group, Nantes, France

PDF源文件 DOI 网页
153 天

Oncolytic adenovirus incorporating TetO sites in the E1A promoter for controlled replication in TetR-expressing mesenchymal stem cells

作者Ramon Alemany; Silvia Torres-Manjon; Laia Traveset; Rafael Moreno

作者单位Cancer Immunotherapy Group, Oncobell and IProCURE programs, IDIBELL-Institut Català D'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Innovation unit, Business Development and Innovation area, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain

PDF源文件 DOI 网页
490 天

Reversible control of CAR T cells through PROTAC compound targeting bromodomain mutant

作者Yeongrin Kim; Da Yeon Lee; Ji U. Choi; Moonjung Jeun; Heung Kyoung Lee; Sang Un Choi; Chi Hoon Park

作者单位Data Convergence Drug Research Center, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea; College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea; Medicinal Chemistry and Pharmacology, University of Science and Technology, Daejeon 34113, Republic of Korea

PDF源文件 DOI 网页
55 天

Feasibility and outcomes of decentralized point-of-care CD19 CAR T cell for relapsed large B cell lymphoma in resource-limited settings

作者Koramit Suppipat; Supannikar Tawinwung; Ornnicha Sathitakorn; Chantiya Chanswangphuwana; Kanhatai Chiengthong; Mutita Surakijboworn; Thiti Asawapanumas; Phandee Watanaboonyongcharoen; Palada Pitakkitnukun; Manaschanok Tippawan; Supanat Kumjan; Udomsak Bunworasate; Nattiya Hirankarn; Kitsada Wudhikarn

作者单位Center of Excellence in Cellular Immunotherapy, Chulalongkorn University, Bangkok 10330, Thailand; Department of Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand; Division of Hematology and Center of Excellence in Translational Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Center of Excellence in Pediatric Hematology/Oncology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Transfusion Medicine Unit, King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand; Transplant and Cellular Therapy Unit, King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand; Center of Excellence in Immunology and Immune-Mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand

PDF源文件 DOI 网页
159 天

Augmenting CAR T cell functionality and metabolism through CD39 downtuning

作者Dennis Christoph Harrer; Jeremy Baldwin; Markus Barden; Hong Pan; Bence Gergely; Árpád Szöőr; György Vereb; Wolfgang Herr; Hinrich Abken

作者单位Department of Hematology and Internal Oncology, University Hospital Regensburg, 93053 Regensburg, Germany; Leibniz Institute for Immunotherapy, Div. Genetic Immunotherapy, Chair Genetic Immunotherapy, University Regensburg, 93053 Regensburg, Germany; Leibniz Institute for Immunotherapy, Div. Functional Immune Cell Modulation, University Regensburg, 93053 Regensburg, Germany; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK; Department of Biophysics and Cell Biology, University of Debrecen Faculty of Medicine, 4032 Debrecen, Hungary; University of Debrecen Faculty of Pharmacy, 4032 Debrecen, Hungary

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。